Comparison of PD-L1 status between primary and paired recurrent/metastatic cervical cancer
ESGO eAcademy. Ataseven B. 10/28/22; 374704
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}